Total Products under this Category: 991
Last updated: September 01, 2026
Why You Can Trust G2's Software Rankings:
G2's software rankings are built on verified user reviews, rigorous moderation, and a consistent research methodology maintained by a team of analysts and data experts. Each product is measured using the same transparent criteria, with no paid placement or vendor influence. While reviews reflect real user experiences, which can be subjective, they offer valuable insight into how software performs in the hands of professionals. Together, these inputs power the G2 Score, a standardized way to compare tools within every category.
Highlighted products: Gemini Enterprise Agent Platform, SAS Viya, IBM watsonx.ai, Azure OpenAI Service, Alteryx, Amazon Personalize, Google Cloud TPU, and Dataiku.
Underlying data: [Grid® JSON](https://www.g2.com/categories/machine-learning/grids.json?focus%5B%5D=gemini-enterprise-agent-platform&focus%5B%5D=sas-sas-viya&focus%5B%5D=ibm-watsonx-ai&focus%5B%5D=azure-openai-service&focus%5B%5D=alteryx&focus%5B%5D=amazon-personalize&focus%5B%5D=google-cloud-tpu&focus%5B%5D=dataiku)
Build Any AI model without writing a single line of code. Use these models for Portfolio optimization, Robo-advisors, Recommendation Engines, Fraud detection and much more
Cofactor Genomics is a biotechnology company specializing in RNA-based predictive diagnostics to enhance precision medicine, particularly in oncology. By analyzing RNA expression profiles, Cofactor develops diagnostic tools that predict patient responses to immunotherapies, aiming to improve treatment outcomes and reduce unnecessary interventions. Their flagship product, OncoPrism®, utilizes machine learning to assess tumor RNA, providing clinicians with actionable insights into immune engagement and therapy responsiveness. This approach addresses the limitations of traditional single-analyte biomarkers by offering a multidimensional perspective on tumor biology. Key Features and Functionality: - RNA-Based Immune Profiling: Cofactor's ImmunoPrism™ platform analyzes RNA from formalin-fixed paraffin-embedded (FFPE) tumor samples to quantify immune cell presence and activity, offering a comprehensive view of the tumor microenvironment. - Machine Learning Integration: The company employs advanced machine learning algorithms to interpret complex RNA data, identifying patterns that predict patient responses to immunotherapies. - Multidimensional Biomarkers: Moving beyond traditional single-analyte biomarkers, Cofactor develops multidimensional RNA biomarkers that provide a more accurate and nuanced understanding of tumor behavior and immune interactions. - Clinical Validation: Products like OncoPrism® have undergone rigorous clinical validation, demonstrating their efficacy in predicting immunotherapy responses across various solid tumor types. Primary Value and User Solutions: Cofactor Genomics addresses the critical challenge of matching cancer patients with the most effective immunotherapies. By providing predictive diagnostics based on RNA analysis, they enable clinicians to make informed treatment decisions, potentially increasing the success rates of immunotherapies and minimizing exposure to ineffective treatments. This personalized approach not only enhances patient outcomes but also contributes to more efficient and cost-effective healthcare delivery.
CoinSignal is an AI-driven platform designed to provide real-time cryptocurrency market insights, enabling traders to make informed decisions without the need to constantly monitor charts. By analyzing technical indicators, fundamental data, and market sentiment, CoinSignal delivers clear BUY, SELL, or HOLD signals accompanied by straightforward explanations. This comprehensive approach ensures users understand the rationale behind each recommendation. Key Features and Functionality: - Automated Trading Signals: CoinSignal generates hourly trading signals for over ten major cryptocurrencies, including BTC, ETH, SOL, XRP, TRX, AVAX, SHIB, PEPE, ADA, SUI, and APT. These signals are based on a combination of technical indicators such as RSI, EMAs, SMA, MACD, and more. - Real-Time News Aggregation: The platform continuously scans over 100 reputable sources every five minutes to provide up-to-date news summaries, helping users stay informed about market-moving events without the need to manually sift through multiple outlets. - Comprehensive Market Analysis: By integrating technical, fundamental, and sentiment analyses, CoinSignal offers a holistic view of the market, enabling users to grasp the full context behind each trading signal. - 24/7 Monitoring: The AI operates around the clock, ensuring that users are promptly informed of potential trading opportunities as they arise, regardless of time zones or market hours. - API Integration: For advanced users and developers, CoinSignal provides an API that allows integration of its features into custom applications or trading bots, enhancing automation and efficiency. Primary Value and User Solutions: CoinSignal addresses the common challenges faced by cryptocurrency traders, such as information overload, emotional decision-making, and the need for constant market monitoring. By delivering concise, AI-generated trading signals and news summaries, the platform empowers users to make data-driven decisions efficiently. This reduces the reliance on subjective interpretations and minimizes the time spent analyzing complex market data, ultimately enhancing trading performance and confidence.
Computomics builds AI-powered predictive breeding software for commercial crop breeding programs. Our machine learning models forecast how a given genotype will perform in a given environment, so breeders can decide which candidates to advance years before multi-location field trials could tell them. The core platform, xSeedScore®, combines genomic data (SNP marker panels, sequence data, pedigree) with environmental data (temperature, precipitation, soil characteristics) and historical field trial measurements. It delivers genomic prediction and genomic selection at the scale of an entire breeding program. Typical questions it answers: which lines hold yield under heat and drought stress, which candidates are stable across environments rather than winning in one, and where a variety should be positioned commercially. CropCompass and BreedScope extend this into variety placement and breeding program analytics. Who we work with: plant breeders and R&D teams in field crops, vegetables, forage crops, and specialty crops, plus agricultural biotech and microbiome research groups. Use cases include genomic selection, genotype-by-environment (GxE) interaction modeling, phenotype prediction, multi-environment trial analysis, hybrid performance prediction, trait discovery, marker-assisted selection support, and variety placement. Why breeders choose us: our machine learning is interpretable, so results can be inspected and defended, not just consumed. We work with your existing data, including messy historical trial records, and we do not require you to restructure your breeding program to get value. Every setup is delivered by a team of machine learning, plant genomics, and bioinformatics specialists rather than handed to a generic data science group. Computomics was founded in 2012 in Tübingen, Germany, as a spin-off from the Max Planck Institute for Biology and the University of Tübingen, with a US entity in Madison, Wisconsin. We have completed more than 200 projects for customers in 22 countries. Keywords: predictive breeding software, genomic prediction, genomic selection, AI for plant breeding, crop performance prediction, GxE modeling, breeding program analytics, agricultural machine learning, bioinformatics services, climate-smart breeding.
